Solid-state 2H and 15N NMR studies of side-chain and backbone dynamics of phospholamban in lipid bilayers: Investigation of the N27A mutation

被引:17
作者
Chu, Shidong [1 ]
Coey, Aaron T. [1 ]
Lorigan, Gary A. [1 ]
机构
[1] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2010年 / 1798卷 / 02期
基金
美国国家科学基金会;
关键词
Phospholamban; Phospholipid membrane; Solid-state NMR; Dynamics; CARDIAC SARCOPLASMIC-RETICULUM; PHOSPHOLIPID-BILAYERS; MAGNETIC-RESONANCE; PROTEIN-STRUCTURE; TRANSMEMBRANE SEGMENT; STRUCTURAL DYNAMICS; MEMBRANE-PROTEINS; SPECTROSCOPY; CA2+-ATPASE; PHOSPHORYLATION;
D O I
10.1016/j.bbamem.2009.09.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phospholamban (PLB) is an integral membrane protein regulating Ca2+ transport through inhibitory interaction with sarco(endo)plasmic reticulum calcium ATPase (SERCA). The Asn27 to Ala (N27A) mutation of PLB has been shown to function as a superinhibitor of the affinity of SERCA for Ca2+ and of cardiac contractility in vivo. The effects of this N27A mutation on the side-chain and backbone dynamics of PLB were investigated with H-2 and N-15 solid-state NMR spectroscopy in phospholipid multilamellar vesicles (MLVs). H-2 and N-15 NMR spectra indicate that the N27A mutation does not significantly change the side-chain or backbone dynamics of the transmembrane and cytoplasmic domains when compared to wild-type PLB. However, dynamic changes are observed for the hinge region, in which greater mobility is observed for the CD3-labeled Ala24 N27A-PLB. The increased dynamics in the hinge region of PLB upon N27A mutation may allow the cytoplasmic helix to more easily interact with the Ca2+-ATPase; thus, showing increased inhibition of Ca2+-ATPase. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:210 / 215
页数:6
相关论文
共 44 条
[31]   Structural characterization of Ca2+-ATPase-bound phospholarnban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) Spectroscopy [J].
Seidel, Karsten ;
Andronesi, Ovidiu C. ;
Krebs, Joachim ;
Griesinger, Christian ;
Young, Howard S. ;
Becker, Stefan ;
Baldus, Marc .
BIOCHEMISTRY, 2008, 47 (15) :4369-4376
[32]   Phospholamban: Protein structure, mechanism of action, and role in cardiac function [J].
Simmerman, HKB ;
Jones, LR .
PHYSIOLOGICAL REVIEWS, 1998, 78 (04) :921-947
[33]   Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals [J].
Stokes, David L. ;
Pomfret, Andrew J. ;
Rice, William J. ;
Glaves, John Paul ;
Young, Howard S. .
BIOPHYSICAL JOURNAL, 2006, 90 (11) :4213-4223
[34]  
TADA M, 1975, J BIOL CHEM, V250, P2640
[35]   Investigating the dynamic properties of the transmembrane segment of phospholamban incorporated into phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy [J].
Tiburu, EK ;
Karp, ES ;
Dave, PC ;
Damodaran, K ;
Lorigan, GA .
BIOCHEMISTRY, 2004, 43 (44) :13899-13909
[36]   Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase [J].
Toyoshima, C ;
Asahi, M ;
Sugita, Y ;
Khanna, R ;
Tsuda, T ;
MacLennan, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (02) :467-472
[37]   Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca2+-ATPaset [J].
Traaseth, Nathaniel J. ;
Ha, Kim N. ;
Verardi, Raffaello ;
Shi, Lei ;
Buffy, Jarrod J. ;
Masterson, Larry R. ;
Veglia, Gianluigi .
BIOCHEMISTRY, 2008, 47 (01) :3-13
[38]   Spectroscopic validation of the pentameric structure of phospholarnban [J].
Traaseth, Nathaniel J. ;
Verardi, Raffaello ;
Torgersen, Kurt D. ;
Karim, Christine B. ;
Thomas, David D. ;
Veglia, Gianluigi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (37) :14676-14681
[39]  
VORHERR T, 1993, PROTEIN SCI, V2, P339
[40]  
WEGENER AD, 1984, J BIOL CHEM, V259, P1834